First Page | Document Content | |
---|---|---|
Date: 2012-06-27 15:01:56Heparins Coagulation system Angiology Transfusion medicine Low molecular weight heparin P-selectin Factor X Angiogenesis E-selectin Biology Cell biology Selectins | Abstract # 5005 M-ONC 402, a novel non-anticoagulant heparin, inhibits P-Selectin function and metastatic seeding of tumor cells in mice Chia Lin Chu, Jay Duffner, Nancy Dussault, Alison Long, Sucharita Roy, Radouane ZAdd to Reading ListSource URL: www.momentapharma.comDownload Document from Source WebsiteFile Size: 1,14 MBShare Document on Facebook |
Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.DocID: 1riKA - View Document | |
Microsoft Wordfile00DocID: 1r9dZ - View Document | |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1qHpD - View Document | |
RECOTHROM, Thrombin topical (Recombinant) Package InsertDocID: 1qv5K - View Document | |
Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deveDocID: 1qk7W - View Document |